最佳证据主题报告。利多卡因作为哮喘持续状态患者快速顺序插管的预处理用药。

Best evidence topic report. Lignocaine as a pretreatment to rapid sequence intubation in patients with status asthmaticus.

作者信息

Butler John, Jackson Rupert

机构信息

Department of Emergency Medicine, Manchester Royal Infirmary, Manchester M13 9WL, UK.

出版信息

Emerg Med J. 2005 Oct;22(10):732. doi: 10.1136/emj.2005.029058.

DOI:10.1136/emj.2005.029058

PMID:16189042

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1726553/

Abstract

A shortcut review was carried out to establish whether pretreatment with intravenous lignocaine is of benefit in asthmatic patients undergoing rapid sequence intubation (RSI). Altogether 157 papers were found using the reported search, of which one presented the best evidence to answer the clinical question. The author, date, and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses of these best papers are tabulated (table 3). It is concluded that there is no good evidence to support the use of lignocaine in this circumstance.

摘要

进行了一项简短综述，以确定静脉注射利多卡因预处理对接受快速顺序诱导插管（RSI）的哮喘患者是否有益。通过报告的检索共找到157篇论文，其中一篇提供了回答该临床问题的最佳证据。这些最佳论文的作者、发表日期、发表国家、研究的患者组、研究类型、相关结局、结果及研究不足均列于表3中。得出的结论是，没有充分证据支持在这种情况下使用利多卡因。